Resilience
Broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.
Launch date
Employees
Market cap
-
Enterprise valuation
€2.3—3.4b (Dealroom.co estimates Jun 2022.)
San Diego California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $50.0m | Series A | |
$800m | Series B | ||
* | N/A | $600m | Series C |
* | N/A | $625m | Series D |
* | N/A | Growth Equity VC | |
* | $410m | Debt | |
Total Funding | €1.9b |
Recent News about Resilience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Resilience
EditACQUISITION by Resilience Apr 2021
ACQUISITION by Resilience Dec 2021